Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Conditions
- Recurrent Fallopian Tube Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Primary Peritoneal Carcinoma
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Paclitaxel
- DRUG: Pazopanib Hydrochloride
- OTHER: Placebo
Sponsor
National Cancer Institute (NCI)
Collaborators